Ledger.Open graph →
SEC Form D · filed June 28, 2016

IFM Therapeutics, Inc

Offering
—
Sold
$17.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Gary Glick · Cambridge, MAExec · DirectorJean-Francois Formela · Broomfield, CODirectorGary Glick · Cambridge, MAExec · DirectorJean-Francois Formela · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗